Inactive Instrument
Irwin Naturals Inc. Stock Canadian Securities Exchange
Stocks
IWIN
CA46414Q1054
Pharmaceuticals
OTC Markets Traded| Market Cap | 483K 424K 395K 362K 680K 46.51M 691K 4.68M 1.83M 22.87M 1.81M 1.77M 79.06M | P/E 2021 |
105x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.45M 17.16M 15.75M 29.59M 2.02B 30.05M 204M 79.62M 995M 78.88M 77.18M 3.44B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.31x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 01/01/1994 |
Mark Green
DFI | Director of Finance/CFO | - | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 18,240 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 1 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 708K | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,067B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 635B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 458B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 347B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 295B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 216B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 203B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 161B | |
| Average | +0.33% | +1.33% | +25.93% | +51.91% | 404.78B | |
| Weighted average by Cap. | +0.55% | +1.95% | +35.81% | +77.68% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 88.13M 81.96M 75.21M 141M 9.66B 143M 973M 380M 4.75B 377M 369M 16.43B | 89.47M 78.58M 73.08M 67.06M 126M 8.62B 128M 868M 339M 4.24B 336M 329M 14.65B |
| Net income | 8.62M 7.57M 7.04M 6.46M 12.13M 830M 12.32M 83.56M 32.65M 408M 32.34M 31.64M 1.41B | -3.99M -3.51M -3.26M -2.99M -5.62M -384M -5.71M -38.72M -15.13M -189M -14.99M -14.66M -653M |
| Net Debt | 9.35M 8.21M 7.64M 7.01M 13.17M 901M 13.37M 90.72M 35.44M 443M 35.11M 34.35M 1.53B | 20.53M 18.03M 16.77M 15.39M 28.91M 1.98B 29.36M 199M 77.79M 972M 77.06M 75.4M 3.36B |
Employees
-
Sector
Pharmaceuticals
